Correlation Between Haemonetics and A SPAC
Can any of the company-specific risk be diversified away by investing in both Haemonetics and A SPAC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Haemonetics and A SPAC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Haemonetics and A SPAC III, you can compare the effects of market volatilities on Haemonetics and A SPAC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Haemonetics with a short position of A SPAC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Haemonetics and A SPAC.
Diversification Opportunities for Haemonetics and A SPAC
0.53 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Haemonetics and ASPC is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding Haemonetics and A SPAC III in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on A SPAC III and Haemonetics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Haemonetics are associated (or correlated) with A SPAC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of A SPAC III has no effect on the direction of Haemonetics i.e., Haemonetics and A SPAC go up and down completely randomly.
Pair Corralation between Haemonetics and A SPAC
Considering the 90-day investment horizon Haemonetics is expected to generate 11.2 times more return on investment than A SPAC. However, Haemonetics is 11.2 times more volatile than A SPAC III. It trades about 0.18 of its potential returns per unit of risk. A SPAC III is currently generating about 0.13 per unit of risk. If you would invest 6,425 in Haemonetics on May 7, 2025 and sell it today you would earn a total of 1,186 from holding Haemonetics or generate 18.46% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Haemonetics vs. A SPAC III
Performance |
Timeline |
Haemonetics |
A SPAC III |
Haemonetics and A SPAC Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Haemonetics and A SPAC
The main advantage of trading using opposite Haemonetics and A SPAC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Haemonetics position performs unexpectedly, A SPAC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in A SPAC will offset losses from the drop in A SPAC's long position.Haemonetics vs. ICU Medical | Haemonetics vs. Merit Medical Systems | Haemonetics vs. The Cooper Companies, | Haemonetics vs. AngioDynamics |
A SPAC vs. Sensient Technologies | A SPAC vs. Chemours Co | A SPAC vs. Molson Coors Beverage | A SPAC vs. Ecolab Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |